Related Experiment Video
Updated: Aug 9, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Immunomodulating activity of 1,2-difattyacyl-3-mercaptoglycerol adducts
M Gemeiner1, E Leidinger, I Miller
1Institut für Medizinische Chemie, Veterinärmedizinische Universität Wien.
Abstract:
Adducts of 1,2-diacyl-(2RS)-3-mercaptoglycerol to 3-maleimidopropionic acid and to 3-maleimidopropionyl-L-alanyl-D-isoglutamine as well as a new lipophilic MTP derivative have been analysed for their immunomodulating activity in comparison to the well known adjuvants CFA and IFA using a suboptimal concentration of BSA as antigen. A concentration-dependent immunostimulating activity was established for these lipophilic molecules when applied in water/oil (IFA) emulsions. The results clearly indicate that the new series of compounds behave as competent adjuvants, a fact which is further supported by the immunoadjuvant effect triggered by two of these diacylthioglyceryl adducts as examples, even when applied in aqueous systems. In the light of these findings it seems promising to use these thiol-functionalized molecules to build in immunoadjuvancy via the maleimide-thiol reaction principle. Attachment of such "sticky fingers" to peptides might enhance interaction of haptens and immunogens with cell membranes and thus, may represent a useful tool for inducing or increasing immunological responses to synthetic antigen presenting systems.
More Related Videos
06:57Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
Related Concept Videos
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents